Grail stock plunges almost 50% after NHS trial misses key goal for Galleri cancer test
NEW YORK, February 20, 2026, 12:32 EST — Regular session Grail shares plunged 49.5% to $51.26 by midday Friday, hitting a session low of $45.51 earlier on. Volume shot past 10 million shares by noon.